DataInsightsOur ThinkingWhitepaper Protected: Disease landscapes: Meaningful scientific and strategic assessments for drug discovery and development There is no excerpt because this is a protected post.Nagendran PMarch 23, 2023
BlogsDataOur Thinking ChEMBL vs. GOSTAR – Data diversity and compound coverage Two of the most popular sources of data for building predictive models are GOSTAR and…Nagendran PMarch 9, 2023
BlogsClinical Data ServicesDataInsightsOur Thinking A day in the life of a clinical pharmacology expert Clinical pharmacologists understand that drug development is a complex and time-consuming activity. Let’s explore how…Nagendran PMarch 9, 2023
DataInsightsOur ThinkingWhitepaper Selecting and preparing data for AI/ML predictive modeling Find out the impact of data selection on the predictive accuracy of AI/ML models and…Nagendran PFebruary 28, 2023
BlogsDataInsightsOur Thinking The role of key opinion leaders in accelerating COVID-19 vaccine use In this blog, we discuss the development of COVID-19 vaccines and the role of KOLs…Nagendran PFebruary 8, 2023
BlogsDataInsights Choosing the appropriate ontology management system for your research An ontology management system (OMS) is a toolkit to support the building, application, and maintenance…Nagendran PFebruary 7, 2023
BlogsData Make better, faster drug development decisions with analysis-ready clinical datasets R&D teams need clinical data quickly available and effectively digitized to support critical decision-making milestones…Nagendran PJanuary 6, 2023
BlogsDataInsights Why you need key opinion leaders (KOLs) in your medical device marketing strategy In this blog post, we’ll discuss the importance of KOLs and thought leaders in marketing…Nagendran PDecember 20, 2022
DataFeaturedInsightsR&D TechnologyWhitepaper Accelerating discovery and creating value Pharmas and biotechs are united by a common goal: discovery. Whether seeking new treatments, improved…Ben.frew@excelra.comOctober 20, 2022
DataWhitepaper Training machine learning algorithms on different data scales Poor drug solubility is one of the main obstacles in drug discovery and development and…Ben.frew@excelra.comOctober 20, 2022